Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)

PHASE3CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

February 28, 2002

Conditions
Renal Insufficiency, Chronic
Interventions
DRUG

paricalcitol

Trial Locations (18)

10029

Mount Sinai School of Medicine, New York

11021

North Shore University Hospital, Great Neck

27609

Wake Nephrology Associates, PA, Raleigh

29209

Dorn VA Hospital, Columbia

33173

Nephrology Association of South Miami, Miami

33603

Tampa Bay Nephrology Associates, Tampa

34667

Outcomes Research International, Inc., Hudson

45220

Kidney and Hypertension Center, Cincinnati

60611

Northwestern University Medical School, Chicago

63110

Washington University School of Medicine, St Louis

64111

Arms, Dodge, Robinson, Wilber and Crouch, Kansas City

65212

University of Missouri Health Sciences Center, Columbia

75235

Dallas Nephrology Associates, Dallas

80260

Western Nephrology, Thornton

89102

NEA Research, Las Vegas

92868

UCI Medical Center, Orange

98644

The Vancouver Clinic, Inc., P.S., Vancouver

Unknown

Jagiellonian University, Krakow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abbott

INDUSTRY